Hudson WA - Search Results

1

EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.

Bindels EM, Havermans M, Lugthart S, Erpelinck C, Wocjtowicz E, Krivtsov AV, Rombouts E, Armstrong SA, Taskesen E, Haanstra JR, Beverloo HB, Döhner H, Hudson WA, Kersey JH, Delwel R, Kumar AR. Bindels EM, et al. Among authors: hudson wa. Blood. 2012 Jun 14;119(24):5838-49. doi: 10.1182/blood-2011-11-393827. Epub 2012 May 2. Blood. 2012. PMID: 22553314 Free PMC article.

2

Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia.

Kumar AR, Hudson WA, Chen W, Nishiuchi R, Yao Q, Kersey JH. Kumar AR, et al. Among authors: hudson wa. Blood. 2004 Mar 1;103(5):1823-8. doi: 10.1182/blood-2003-07-2582. Epub 2003 Nov 13. Blood. 2004. PMID: 14615372 Free article.

3

A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy.

Chen W, Li Q, Hudson WA, Kumar A, Kirchhof N, Kersey JH. Chen W, et al. Among authors: hudson wa. Blood. 2006 Jul 15;108(2):669-77. doi: 10.1182/blood-2005-08-3498. Epub 2006 Mar 21. Blood. 2006. PMID: 16551973 Free PMC article.

4

Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells.

Chen W, Kumar AR, Hudson WA, Li Q, Wu B, Staggs RA, Lund EA, Sam TN, Kersey JH. Chen W, et al. Among authors: hudson wa. Cancer Cell. 2008 May;13(5):432-40. doi: 10.1016/j.ccr.2008.03.005. Cancer Cell. 2008. PMID: 18455126 Free PMC article.

5

A role for MEIS1 in MLL-fusion gene leukemia.

Kumar AR, Li Q, Hudson WA, Chen W, Sam T, Yao Q, Lund EA, Wu B, Kowal BJ, Kersey JH. Kumar AR, et al. Among authors: hudson wa. Blood. 2009 Feb 19;113(8):1756-8. doi: 10.1182/blood-2008-06-163287. Epub 2008 Dec 24. Blood. 2009. PMID: 19109563 Free PMC article.

6

Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.

Johnson JJ, Chen W, Hudson W, Yao Q, Taylor M, Rabbitts TH, Kersey JH. Johnson JJ, et al. Blood. 2003 Apr 15;101(8):3229-35. doi: 10.1182/blood-2002-05-1515. Epub 2002 Dec 19. Blood. 2003. PMID: 12515728 Free article.

7

Modeling human infant MLL leukemia in mice: leukemia from fetal liver differs from that originating in postnatal marrow.

Chen W, O'Sullivan MG, Hudson W, Kersey J. Chen W, et al. Blood. 2011 Mar 24;117(12):3474-5. doi: 10.1182/blood-2010-11-317529. Blood. 2011. PMID: 21436082 Free PMC article. No abstract available.

8

FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases.

Yao Q, Nishiuchi R, Li Q, Kumar AR, Hudson WA, Kersey JH. Yao Q, et al. Among authors: hudson wa. Clin Cancer Res. 2003 Oct 1;9(12):4483-93. Clin Cancer Res. 2003. PMID: 14555522

9

Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects.

Hudson WA, Li Q, Le C, Kersey JH. Hudson WA, et al. Leukemia. 1998 Dec;12(12):2029-33. doi: 10.1038/sj.leu.2401236. Leukemia. 1998. PMID: 9844934

10

Pharmacokinetics and biodistribution of radioimmunoconjugates of anti-CD19 antibody and single-chain Fv for treatment of human B-cell malignancy.

Li Q, Hudson W, Wang D, Berven E, Uckun FM, Kersey JH. Li Q, et al. Cancer Immunol Immunother. 1998 Nov;47(3):121-30. doi: 10.1007/s002620050512. Cancer Immunol Immunother. 1998. PMID: 9829837 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page